A federal district court in Washington, D.C., heard arguments this week in Novartis and United Therapeutics' 340B contract pharmacy lawsuits.

A Closer Look at Critical Court Hearing on 340B Contract Pharmacy Legality

U.S. District Judge Dabney Friedrich all but told the federal government during a court hearing in Washington, D.C., on Tuesday she rejects its basic argument that the plain text of the 340B statute requires drug manufacturers to honor 340B purchases by covered entities regardless of whether those entities use contract pharmacy services.

Friedrich spent much of the 90-minute hearing quizzing lawyers for drug makers Novartis and United Therapeutics and the federal government about other possible grounds upon which the government might win the cases that the two companies have brought against it.

U.S. District Judge Dabney Friedrich all but told the federal government during a court hearing in Washington, D.C., on Tuesday she rejects its basic argument that the plain text of 340B statute requires drug manufacturers to honor 340B purchases by covered entities regardless of whether those entities use contract pharmacy services.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

×

*Sign up for news summaries and alerts from 340B Report

Site Footer